NEWRON PHARMACEUTICALS SPA (NP5.DE) Stock Analyst Ratings

Europe • Frankfurt Stock Exchange • FRA:NP5 • IT0004147952

22.2 EUR
+1.3 (+6.22%)
Last: Feb 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to NP5.DE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 51.9. This target is 133.76% above the current price.
  • NP5.DE was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NP5.DE.
  • In the previous month the buy percentage consensus was at a similar level.
  • NP5.DE was analyzed by 10 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
NP5.DE Historical Analyst RatingsNP5.DE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 22.2027.3347.4851.9082.97 - 23.12% 113.87% 133.76% 273.76%

Related screens

Find peers 30% below price target
NP5.DE Current Analyst RatingNP5.DE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades

NEWRON PHARMACEUTICALS SPA / NP5.DE FAQ

What do analysts expect the price target to be for NEWRON PHARMACEUTICALS SPA (NP5.DE)?

10 analysts have analysed NP5.DE and the average price target is 51.9 EUR. This implies a price increase of 133.76% is expected in the next year compared to the current price of 22.2.


What is the consensus rating for NEWRON PHARMACEUTICALS SPA (NP5.DE) stock?

The consensus rating for NEWRON PHARMACEUTICALS SPA (NP5.DE) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.